WHO Pharmaceuticals Newsletter 1999, No. 03&04
(1999; 16 pages)
Table des matières
Ouvrir ce répertoire et afficher son contenuRegulatory actions
Ouvrir ce répertoire et afficher son contenuDrug surveillance
Fermer ce répertoireNew developments
Afficher le documentDenileukin diftitox: novel treatment for rare form of cancer approved: USA
Afficher le documentDesirudin: approved for use in orthopaedic surgery: UK
Afficher le documentEtonorgestrel: single implant contraceptive: UK
Afficher le documentLevonorgestrel: progestogen-only emergency contraception available: UK
Afficher le documentMaggots: use in infected and necrotic wounds: UK
Afficher le documentTemozolomide: a new treatment for brain cancer: UK
Afficher le documentVaccine for Lyme disease: approved: USA
Afficher le documentNew indications
Afficher le documentNew formulations
Afficher le documentNewly approved products
Ouvrir ce répertoire et afficher son contenuMedical devices
Ouvrir ce répertoire et afficher son contenuMedication errors
Ouvrir ce répertoire et afficher son contenuVeterinary medicine
 

Newly approved products

*first listing

4-aminosalicylic acid (4-amino-2-hydroxybenzoic acid)

Quadrasa, Norgine: Germany

powder for reconstitution 2 g (for rectal administration)

anti-inflammatory agent

Indications: Treatment of mild to moderate active distal ulcerative colitis.

*balsalazide

Colazide, Astra: Switzerland

capsule 750-mg

anti-inflammatory agent

Indication: Ulcerative colitis.

botulism toxin

Botox: Allergan: Germany

injection solution Clostridium botulinum toxin type A/haemagglutinin complex 100 units/vial

Clostridium botulinum type A toxin-haemagglutinin complex

Indications: Treatment of blepharospasm and coexisting hemifacial dystonia in adults; symptomatic treatment of idiopathic spasmodic torticollis; sequelae of infantile cerebral palsy (2 years and older).

*brimonidine tartrate

Alphagan, Allergan: Switzerland

eyedrops 0.2% (2-mg/ml)

a2-adrenoreceptor agonist

Indications: Wide-angle glaucoma, ocular hypertension.

*capecitabine

Xeloda: Roche: Germany, Switzerland

coated tablets 150-mg, 500-mg

antineoplastic agent

Indication: Treatment of colorectal cancer.

cefepime

Maxipime, Bristol-Myers Squibb: Australia

solution for injection 500 mg in 15 mL vials, 1 g in 15 mL vials, 2 g in 77 mL vials

cefalosporin antibiotic

Indications: Septicaemia, peritonitis, genito- urinary tract infections or infections due to susceptible microorganisms.

danaparoid sodium

Orgaran, Organon: Germany

injection fluid 750 anti-Xa units/0.6 ml ampoule

low molecular weight heparinoid

Indications: Prophylaxis of deep vein thrombosis when heparin is not indicated, especially in patients with heparin-induced thrombocytopenia (type II); treatment of thromboembolic diseases in patients who need an immediate parenteral anticoagulant and either develop or have a history of heparin-induced thrombocytopenia.

daunorubicin

DaunoXome: NeXstar: Australia

concentrated solution for injection 50-mg/25 mL (liposomal daunorubicin)

antineoplastic agent

Indications: AIDs-related Kaposi’s sarcoma.

*dorzolamide + timolol

Cosopt, Dorzolamid/Timolol: Chibret: Germany

eyedrops 20-mg + 5-mg/ml

carbonic anhydrase inhibitor + ß-adrenoreceptor antagonist

Indications: Treatment of raised intra-ocular pressure in patients with wide-angle glaucoma or pseudoexfoliative glaucoma when monotherapy with a ß-adrenoreceptor antagonist is ineffective.

efavirenz

Stocrin: MSD: Switzerland

capsules 50-mg, 100-mg, 200-mg

antiviral agent

Indications: Infections due to HIV.

Note: See also Pharmaceuticals Newsletter Nos. 11&12, November & December 1998.

ibandronic acid

Bondronat, Boehringer Mannheim: EU

infusion concentrate 1-mg/ml, 2-mg/2ml

biphosphonate

Indication: Treatment of hypercalcaemia caused by malignant tumours.

imidapril hydrochloride

Imidapril Thiemann; Tanatril: Thiemann: Germany

tablets 2.5-mg, 5-mg, 10-mg, 20-mg

angiotensin-converting enzyme (ACE) inhibitor

Indications: Essential hypertension.

*imiquimod

Aldara, Zartra: 3M Santé: EU

topical cream 5% w/w (sachets 250-mg)

immune response modifier

Indication: Topical treatment of external genital and perianal warts (condyloma acuminata).

Adverse reactions: Itching, burning, pain; headache, influenza-like symptoms, myalgia.

irbesartan

Aprovel: Sanofi Pharma Bristol-Myers Squibb: EU, Norway

tablet 150-mg, 300-mg

angiotensin II antagonist; antihypertensive

Indication: Hypertension.

*irbesartan + hydrochlorothiazide

Karvezide, Bristol-Myers Squibb Pharma EEIG: EU CoAprovel, Sanofi Pharma Bristol-Myers Squibb

tablets 150-mg + 12.5-mg, 300-mg + 12.5-mg

angiotensin II antagonist; antihypertensive + thiazide diuretic

Indication: Essential hypertension.

latanoprost

Xalatan, Pharmacia & Upjohn: Spain

eyedrops 50 micrograms/ml (vial 2.5 ml)

antiglaucoma agent

Indications: [Not stated].

leflunomide

Arava, Hoechst Marion Roussel: Switzerland

tablets 10-mg, 20-mg, 100-mg

nonsteroidal anti-inflammatory agent (NSAID)

Indications: Active rheumatoid arthritis.

Note: See also Pharmaceuticals Newsletter Nos. 9&10, September & October 1998.

nonacog alfa

BeneFIX, Genetics Institute: EU

powder for reconstitution (intravenous injection) 250, 500, 1000 IU/vial

recombinant human coagulation factor IX

Indications: Control and prevention of haemorrhagic episodes and for routine and surgical prophylaxis in previously treated patients with Haemophilia B.

omeprazole magnesium

Antra MUPS, Gastroloc MUPS, Astra: Germany

enteric-coated capsule 10.3-mg, 20.6-mg, 41.3-mg (10-mg, 20-mg, 40-mg omeprazole)

anticholinergic antisecretory agent

Indications: Recurrent reflux oesophagitis and duodenal ulcer.

perindopril erbumine + indapamide

Bi Preterax; Bi Predenium, Servier: Germany

tablet 4-mg + 1.25-mg

angiotensin-converting enzyme (ACE) inhibitor + thiazide diuretic

Indications: Essential hypertension when monotherapy has failed.

rabeprazole sodium

Pariet, Eisai: Germany, UK

enteric coated cap sule 10-mg, 20-mg

antisecretory agent

Indications: Treatment of active duodenal ulcer, active benign gastric ulcer or symptomatic erosive or ulcerative gastro-oesophageal reflux disease (GORD).

Contraindications, precautions & warnings: As for other drugs of this class.

raloxifene hydrochloride

Celvista; Evista, Eli Lilly: EU, Germany, UK

tablet 60-mg

selective estrogen receptor modulator

Indications: Prevention of non-traumatic vertebral fractures in postmenopausal women at increased risk of osteoporosis.

reboxetine

Edronax, Pharmacia & Upjohn: Germany

scored tablet 4-mg

noradrenaline antagonist; antidepressant

Indications: Depressive illness.

reteplase

Rapilysin, Boehringer Mannheim: Australia

powder for reconstitution 10 Units/vial

recombinant human tissue plasminogen activator (TPA)

Indication: Myocardial infarction.

*rivastigmine

Prometax, Novartis: EU

hard capsules 1.5-mg, 3-mg, 4.5-mg, 6-mg

acetylcholinesterase inhibitor

Indications: Symptomatic treatment of mild to moderately severe Alzheimer’s dementia.

*rizatriptan

Maxalt lingua; Maxalt tablets, MSD: Germany

melt wafers 5-mg, 10-mg; tablets 5-mg, 10-mg

serotonin receptor agonist

Indications: Acute treatment of headache due to migraine attacks with and without aura.

Note: See also Pharmaceuticals Newsletter Nos. 11&12, November & December 1998.

tacrolimus

Prograf, Janssen-Cilag: Australia

capsules 1-mg, 5-mg; solution for injection 5-mg/ml

immunosuppressant

Indications: Immunosuppression for liver transplantation.

*telmisartan

Micardis, Boehringer Ingelheim; Pritor, Glaxo Wellcome: Switzerland

tablet 40-mg, 80-mg

angiotensin II antagonist; antihypertensive

Indication: Hypertension.

temocapril

Acecor, Sankyo: Germany

coated tablets 5-mg, 10-mg, 20-mg

angiotensin-converting enzyme (ACE) inhibitor

Indication: Essential hypertension.

tiludronic acid

Skelid, Sanofi Winthrop: Australia

tablet 200-mg

biphosphonate

Indication: Osteitis deformans (Paget’s disease).

topiramate

Topamax; Topiramat-Cilag, Janssen-Cilag: Australia, Germany

tablets 25-mg, 50-mg, 100-mg, 200-mg

Germany: also 300-mg, 400-mg

antiepileptic agent Indications: Adjunctive therapy in epilepsy for adults with partial onset epileptic seizures with or without secondary generalized seizures.

 

vers la section précédente vers la section suivante
 

Dernière mise à jour: le 3 mai 2013